Insiders Personalis, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 09/05/2024 BST			5-day change	1st Jan Change
1.65 ^USD	+5.43%		+3.12%	-21.43%

05-08	Transcript : Personalis, Inc., Q1 2024 Earnings Call, May 08, 2024
05-08	Earnings Flash (PSNL) PERSONALIS Reports Q1 Revenue $19.5M, vs. Street Est of $18.4M	MT

Personalis, Inc. Appoints Deepshikha Bhandari as SVP, Regulatory, Quality and Clinical Compliance	19/10/23	CI
Personalis, Inc. Announces Board Changes	14/06/23	CI
Personalis Appoints Christopher Hall Chief Executive Officer, Aaron Tachibana Chief Operating Officer	03/03/23	MT
Personalis, Inc. Announces Executive Changes	02/03/23	CI
Personalis, Inc. Appoints Christopher Hall as Chief Executive Officer	02/03/23	CI
Personalis CFO Aaron Tachibana Named Interim CEO After Incumbent Announces Plan to Retire	14/12/22	MT
Personalis, Inc. Announces Retirement of John West from the Board of Directors	14/12/22	CI
Personalis, Inc. Announces Retirement of John West as CEO	14/12/22	CI
Personalis, Inc. Appoints Christopher Hall as SVP and Head, Diagnostics Business	31/10/22	CI
Personalis, Inc. Appoints Lonnie Shoff to Its Board of Directors	03/08/22	CI
Personalis, Inc. Announces Board Changes	24/03/22	CI
Insider Sell: Personalis	20/01/22	MT
Insider Sell: Personalis	20/12/21	MT
Personalis Named to Inc.'s 2021 Best-Led Companies List	12/11/21	BU
Insider Sell: Personalis	15/10/21	MT
Personalis, Inc. Announces Board Changes	08/03/21	CI
Personalis, Inc. Announces Appointment of Susan Moriconi as VP of People and Chief Human Resources Officer	08/02/21	CI
Personalis, Inc. Appoints Kevin Dunne as New Head of Population Genomics	15/09/20	CI
Personalis, Inc. Appoints Stephen Moore as General Counsel	05/05/20	CI
Personalis, Inc. Elects Karin Eastham to the Board as Class III Director	12/09/19	CI

No results for this search